Revlimid
I read with great interest the lengthy article about the Eu deciding against allowing Revlimid. It is very disappointing, but apparently there was this unexplained transformation to AML that was statistically significant. Any comments? It has been used for a few years in the U.S. and has anyone heard any similar stats?
|